HB is a "second-generation microbiome company" specializing in the development of donor-independent synthetic microbiomes, such as NGBs (Next-Generation Biologics). The term "second-generation" emphasizes their focus on creating synthetic microbiome drugs from the start. Rather than investing in registering FMT (Fecal Microbiota Transplant), which may be unprofitable, HB prioritizes developing artificial microbiota synthesis t...
HB is a "second-generation microbiome company" specializing in the development of donor-independent synthetic microbiomes, such as NGBs (Next-Generation Biologics). The term "second-generation" emphasizes their focus on creating synthetic microbiome drugs from the start. Rather than investing in registering FMT (Fecal Microbiota Transplant), which may be unprofitable, HB prioritizes developing artificial microbiota synthesis technology. The goal is to produce fully synthetic, context-based microbiota, addressing significant challenges in medicine.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.